Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Toxicology|November 6, 2003
A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studiesMaritha Marcusson-Ståhl, Karin Cederbrant
Journal of Biomedicine & Biotechnology|October 15, 2009
Meso scale discovery and luminex comparative analysis of calbindin D28KSamer Sourial, Maritha Marcusson-Ståhl, Karin Cederbrant
Toxicology|February 13, 2003
NK-cell activity in immunotoxicity drug evaluationKarin Cederbrant, Maritha Marcusson-Ståhl, Fabienne Condevaux, et al.
Contact Dermatitis|October 15, 2014
Sensitization to omeprazole in the occupational settingPer Hamid Ghatan, Maritha Marcusson-Ståhl, Mihaly Matura, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 6, 2018
Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot studyKnut Tore Lappegård, Christian Abendstein Kjellmo, Stefan Ljunggren, et al.
Biomedicines|August 26, 2022
Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia: A Randomized Crossover TrialLiv Nesse Hande, Christian Kjellmo, Kristin Pettersen, et al.
Nanotoxicology|September 1, 2021
Protein interaction, monocyte toxicity and immunogenic properties of cerium oxide crystals with 5% or 14% gadolinium, cobalt oxide and iron oxide nanoparticles - an interdisciplinary approachMaria Assenhöj, Peter Eriksson, Pierre Dönnes, et al.
Journal of Clinical Lipidology|November 18, 2017
Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacityChristian Abendstein Kjellmo, Helen Karlsson, Torunn K Nestvold, et al.
Immunology and Cell Biology|March 24, 2018
Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosisEllen Iacobaeus, Iyadh Douagi, Regina Jitschin, et al.
Toxicologic Pathology|December 2, 2011
Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studiesPer Lindblom, Anna-Lena Berg, Hui Zhang, et al.
Pageof 2